APRI (Aprinoia Therapeutics) Total Equity: $-100.49 Mil (As of Dec. 2023)


What is Aprinoia Therapeutics Total Equity?

Aprinoia Therapeutics APRI Total Equity is $-100.49 Mil as of Dec. 2023.

Aprinoia Therapeutics's total equity for the quarter that ended in Dec. 2023 was $-100.49 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Aprinoia Therapeutics Total Equity Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Total Equity Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Total Equity
-48.69 -75.45 -100.49

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Total Equity -48.69 0.00 -75.45 -81.93 -100.49

Aprinoia Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Aprinoia Therapeutics's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=4.946-105.435
=-100.49

Aprinoia Therapeutics's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=4.946-105.435
=-100.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-100.49 Mil mean?
Aprinoia Therapeutics (APRI) has a Total Equity of $-100.49 Mil as of Dec. 2023. The total amount of equity as record on a company's balance sheet. View historical data for Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Total Equity too high?
Aprinoia Therapeutics' current Total Equity is $-100.49 Mil.
How does Aprinoia Therapeutics' Total Equity compare to ?
Aprinoia Therapeutics' Total Equity of $-100.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Total Equity is $-100.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Total Equity of $-100.49 Mil. The current Total Equity is $-100.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Total Equity is $-100.49 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.